Home > Riviste > Minerva Pediatrics > Fascicoli precedenti > Articles online first > Minerva Pediatrics 2021 Dec 03

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Pediatrics 2021 Dec 03

DOI: 10.23736/S2724-5276.21.06564-2

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Hepatitis C virus-specific markers in pediatric patients with chronic hepatitis C

Lyudmila NIKOLAEVA 1 , Elena LEYBMAN 1, 2, Evgeniy SAMOKHVALOV 1, Karen KYUREGYAN 3, Vera KICHATOVA 3, Olga ISAEVA 3, Victor KUPRIANOV 4

1 Department of Molecular Virology, Ivanovsky Institute of Virology, Gamaleya National Research Centre of Epidemiology and Microbiology, Ministry of Health, Moscow, Russian Federation; 2 Department of Children’s Infectious Diseases, Pirogov Russian National Research Medical University, Ministry of Health, Moscow, Russian Federation; 3 Department of Virology, Russian Medical Academy of Continuing Professional Education, Ministry of Health, Moscow, Russian Federation; 4 Department of Molecular Biology of Microorganisms, Skryabin Institute of Bioengineering, Federal Research Centre Fundamentals of Biotechnology, Russian Academy of Sciences, Moscow, Russian Federation


PDF


BACKGROUND: The study aimed to investigate hepatitis C virus (HCV) specific markers in chronically infected children. The main objective was to explore the patterns of marker variability.
METHODS: HCV RNA, core antigen, anti-HCV IgM, and antibodies to individual viral proteins were detected using commercially available assays or experimental ELISA. RNA genotyping and recombination were performed by sequencing.
RESULTS: HCV RNA and core antigen were detected in serum samples of all children (n=100). Anti-HCV IgM, anti-NS4AB IgG, and anti-NS5A IgG were revealed less often than antibodies to core and NS3 proteins. To elucidate the cause of this finding, all subjects were divided into 4 groups differing in hepatitis duration. It was anti-NS4AB only whose detection depended on the infection duration. A trend was established that the longer the hepatitis duration, the more frequently anti-HCV IgM was observed. No significant impact of HCV RNA load and NS4A/NS4B amino acid substitutions on anti-NS4AB IgG detection was found. The increase HCV genotype 3 was observed among children infected after 2000. The earliest case of infection caused by HCV intergenotype recombinant RF1_2k/1b was identified in a child vertically infected in 1997.
CONCLUSIONS: HCV genotypes and subtypes were found to be variable virus specific markers in children infected in 1997-2015. Over the period, there has been a trend to change the dominant HCV subtype and appearance of recombinant RF1_2k/1b in children. Among humoral markers, anti-NS4AB revealing is depended on chronic hepatitis C duration, while for anti-HCV IgM, only a trend was established. The detection of anti-NS4AB can be helpful in assessing the duration of chronic hepatitis C.


KEY WORDS: Child; Hepatitis C; HCV; Genotypes; Antigen; Antibodies; Amino acid substitution

inizio pagina